Ernexa Therapeutics appoints Robert J. Spiegel to board of directors

PUBT · 3d ago
Ernexa Therapeutics appoints Robert J. Spiegel to board of directors
  • Ernexa Therapeutics appointed Robert J. Spiegel to its board as it sharpens its oncology focus and advances ERNA-101.
  • Spiegel spent more than 25 years at Schering-Plough Research Institute, most recently serving as chief medical officer.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ernexa Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610010920PRIMZONEFULLFEED9837345) on October 01, 2026, and is solely responsible for the information contained therein.